查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1937085

全球神经科学市场规模、份额、趋势和成长分析报告（2026-2034）

Global Neuroscience Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计神经科学市场将从 2025 年的 567.3 亿美元成长到 2034 年的 967.4 亿美元，2026 年至 2034 年的复合年增长率为 6.11%。

由于阿兹海默症、帕金森氏症和多发性硬化症等神经系统疾病的日益增多，神经科学市场预计将迎来显着成长。随着全球人口老化和慢性病负担的加重，神经科学领域对有效诊断和治疗方案的需求激增。神经影像技术、生物标记发现和药物研发的进步正在改变神经系统疾病的治疗格局，使医疗服务提供者能够提供更具针对性和个人化的治疗。随着研究人员和临床医生致力于改善神经系统疾病患者的治疗效果和生活质量，这一趋势预计将推动市场格局的发展。

调查方法和技术的创新正在塑造神经科学市场的未来前景。人工智慧和机器学习的融合提高了分析复杂神经学数据的能力，从而改善了患者分层和治疗效果。此外，神经刺激技术和神经调控疗法的进步为神经系统疾病的治疗开闢了新途径，为患者提供了非侵入性的症状缓解方案。随着研究不断揭示神经系统疾病的潜在机制，针对疾病进展特定路径的新型治疗方法有望陆续推向市场。

此外，随着製药公司和学术机构认识到神经科学领域创新解决方案的紧迫性，加强研发投入将对神经科学市场产生正面影响。神经科、研究人员和行业相关人员之间的合作对于推进临床试验和确保新疗法的应用至关重要。在这种不断变化的环境下，监管机构有望简化创新治疗方法的核准流程，使神经系统疾病患者能够更快地获得有效的治疗方案。将神经科学融入综合医疗保健策略将变得日益重要，这将进一步凸显早期诊断、病​​患教育和持续支持在神经系统疾病管理中的重要性。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 绘製渗透率和成长前景图
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 市场机会
    • 市场问题
  • 波特五力分析
  • PESTLE分析

4. 全球神经科学市场（按组成部分划分）

  • 市场分析、洞察与预测
  • 装置
  • 消耗品
  • 软体和服务

5. 全球神经科学市场（依技术划分）

  • 市场分析、洞察与预测
  • 脑部影像
  • 神经显微镜
  • 立体定位手术
  • 神经蛋白质体学分析
  • 神经元操控
  • 其他的

6. 全球神经科学市场（依最终用户划分）

  • 市场分析、洞察与预测
  • 医院
  • 诊断检查室
  • 研究和学术机构

7. 全球神经科学市场（按地区划分）

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商格局（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Carl Zeiss AG
    • Danaher Corporation
    • GE Healthcare
    • Siemens Healthcare Private Limited
    • Koninklijke Philips NV
    • Canon Inc
    • B. Braun SE
    • Medtronic
    • Stryker
    • Boston Scientific Corporation
    • Abbott
    • Terumo Corporation
简介目录
Product Code: VMR11215038

The Neuroscience Market size is expected to reach USD 96.74 Billion in 2034 from USD 56.73 Billion (2025) growing at a CAGR of 6.11% during 2026-2034.

The neuroscience market is poised for substantial growth, driven by the increasing prevalence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. As the global population ages and the burden of chronic diseases rises, the demand for effective diagnostic and therapeutic solutions in neuroscience is surging. Advances in neuroimaging, biomarker discovery, and drug development are transforming the landscape of neurological care, enabling healthcare providers to offer more targeted and personalized treatment options. This trend is expected to propel the market forward, as researchers and clinicians seek to improve patient outcomes and enhance the quality of life for individuals with neurological conditions.

Innovations in research methodologies and technologies are shaping the future of the neuroscience market. The integration of artificial intelligence and machine learning is enhancing the ability to analyze complex neurological data, leading to improved patient stratification and treatment outcomes. Additionally, advancements in neurostimulation techniques and neuromodulation therapies are providing new avenues for managing neurological disorders, offering patients non-invasive options for symptom relief. As research continues to uncover the underlying mechanisms of neurological diseases, the market is likely to witness the introduction of novel therapies that target specific pathways involved in disease progression.

Moreover, the neuroscience market will benefit from increased investment in research and development, as pharmaceutical companies and academic institutions recognize the urgent need for innovative solutions in this field. Collaborative efforts between neurologists, researchers, and industry stakeholders will be essential in advancing clinical trials and ensuring the successful implementation of new therapies. As the landscape evolves, regulatory bodies are expected to streamline approval processes for innovative treatments, facilitating faster access to effective solutions for patients with neurological disorders. The focus will increasingly shift towards integrating neuroscience into comprehensive healthcare strategies, emphasizing the importance of early diagnosis, patient education, and ongoing support in managing neurological conditions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

  • Instruments
  • Consumables
  • Software & Services

By Technology

  • Brain Imaging
  • Neuro-Microscopy
  • Stereotaxic Surgeries
  • Neuro-Proteomic Analysis
  • Neuro-Cellular Manipulation
  • Others

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Research And Academic Institute

COMPANIES PROFILED

  • Carl Zeiss AG, Danaher Corporation, GE Healthcare, Siemens Healthcare Private Limited, Koninklijke Philips NV, Canon Inc, B Braun SE, Medtronic, Stryker, Boston Scientific Corporation, Abbott, Terumo Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROSCIENCE MARKET: BY COMPONENT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Component
  • 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROSCIENCE MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Brain Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Neuro-Microscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Stereotaxic Surgeries Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Neuro-Proteomic Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Neuro-Cellular Manipulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROSCIENCE MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Research And Academic Institute Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEUROSCIENCE MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Component
    • 7.2.2 By Technology
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Component
    • 7.3.2 By Technology
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Component
    • 7.4.2 By Technology
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Component
    • 7.5.2 By Technology
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Component
    • 7.6.2 By Technology
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEUROSCIENCE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Carl Zeiss AG
    • 9.2.2 Danaher Corporation
    • 9.2.3 GE Healthcare
    • 9.2.4 Siemens Healthcare Private Limited
    • 9.2.5 Koninklijke Philips N.V
    • 9.2.6 Canon Inc
    • 9.2.7 B. Braun SE
    • 9.2.8 Medtronic
    • 9.2.9 Stryker
    • 9.2.10 Boston Scientific Corporation
    • 9.2.11 Abbott
    • 9.2.12 Terumo Corporation